InsidersTradesSigma
Explore the complete record of transactions filed by Iris Loew-Friedrich, 董事. Director active across 2 companies, notably Swedish Orphan Biovitrum AB (publ). Aggregated, 1 filings have been published. Activity tracked since 10 February 2026. The latest transaction was disclosed on 10 February 2026 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Iris Loew-Friedrich is a board member of Swedish Orphan Biovitrum AB. In this role, she participates in strategic discussions and decision-making within the board. Iris brings expertise in the pharmaceutical sector, thus contributing to the strategic direction of the company. Her commitment to ethics and accountability is an asset for Swedish Orphan Biovitrum.